Price target upside
Teva Pharmaceutical Industries Price Target: +17.8% vs Current Price
Direct answer
Teva Pharmaceutical Industries's analyst target implies +17.8%.
The average target is $47.58 compared with a recorded current price of $40.39.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked October 27, 2026.
Get free Teva Pharmaceutical Industries email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $40.39
- Average price target
- $47.58
- High price target
- $55.00
- Low price target
- $42.00
- Low target gap
- +4%
- Target upside
- +17.8%
- High target gap
- +36.2%
- Target range width
- 32.2%
- Consensus rating
- Strong Buy
- Analysts
- 12
- Evidence date
- October 27, 2026
- Valid through
- November 3, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does Teva Pharmaceutical Industries's average target imply?
Teva Pharmaceutical Industries's average target is $47.58 versus a recorded price of $40.39. The difference is +17.8%.
How far are Teva Pharmaceutical Industries's low and high targets from the recorded price?
The low target implies +4%, while the high target implies +36.2%.
How many analysts are included in Teva Pharmaceutical Industries's consensus?
The verified consensus includes 12 analysts.
How is Teva Pharmaceutical Industries's target upside or downside calculated?
The average target of $47.58 is divided by the recorded price of $40.39, then one is subtracted to produce +17.8%. This does not guarantee a future return.
When was Teva Pharmaceutical Industries's analyst forecast verified?
The data was verified on 2026-10-27. The dataset is valid through 2026-11-03.